EMEA-000334-PIP01-08-M11 - paediatric investigation plan

Methoxyflurane

Key facts

• Invented name:
  Penthrox
• Active Substance:
  Methoxyflurane
• Therapeutic area:
  Pain
• Decision number:
  P/0080/2023
• PIP number:
  EMEA-000334-PIP01-08-M11
• Pharmaceutical form(s):
  Inhalation vapour (liquid)
• Condition(s) / indication(s):
  Treatment of acute pain
• Route(s) of administration:
  Inhalation use
• Contact for public enquiries:

  Medical Developments UK Ltd

  Email: [e-mail]; Tel. + 61 395471888

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  13/03/2023

Decision

P/0080/2023 : EMA decision of 13 March 2023 on the acceptance of a modification of an agreed paediatric investigation plan for methoxyflurane (Penthrox and associated names) (EMEA-000334-PIP01-08-M11)